Immunome, Inc. (IMNM)

Immunome Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	165.33	98.68	20.32	49.23	39.77	2.54
Short-Term Investments	113.02	43.47	-	-	-	-
Cash & Short-Term Investments	278.35	142.15	20.32	49.23	39.77	2.54
Cash Growth	624.58%	599.46%	-58.72%	23.80%	1463.74%	58.74%
Accounts Receivable	-	-	-	1.64	-	-
Other Receivables	-	0.29	0.85	2.67	0.85	-
Receivables	-	0.29	0.85	4.31	0.85	-
Prepaid Expenses	5.93	1.67	1.03	2.51	2.28	0.58
Other Current Assets	-	0.6	0.45	0.59	-	-
Total Current Assets	284.28	144.7	22.65	56.64	42.89	3.12
Property, Plant & Equipment	8.62	3.64	0.97	0.86	1.53	1.7
Long-Term Deferred Charges	-	-	0.33	0.33	-	-
Other Long-Term Assets	3.31	0.2	0.1	0.1	0.1	0.24
Total Assets	296.22	148.54	24.05	57.93	44.53	5.06
Accounts Payable	7.05	3.31	2.4	3.08	1.19	0.55
Accrued Expenses	19.19	7.52	4.62	4.31	1.27	0.67
Current Portion of Long-Term Debt	-	-	-	-	0.48	0.21
Current Portion of Leases	0.3	0.31	0.23	-	-	0.24
Current Unearned Revenue	12.59	10.49	-	-	-	-
Other Current Liabilities	0.78	0.2	0.09	2.34	0.1	-
Total Current Liabilities	39.9	21.83	7.33	9.73	3.04	1.67
Long-Term Debt	-	-	-	-	0.13	0.11
Long-Term Leases	2.48	1.34	0.06	-	-	-
Long-Term Unearned Revenue	-	5.49	-	-	-	-
Other Long-Term Liabilities	-	-	-	0.01	0.01	0.02
Total Liabilities	42.38	28.66	7.39	9.74	3.18	1.8
Common Stock	0.01	0	0	0	0	-
Additional Paid-In Capital	642.25	342.66	132.65	127.29	95.74	0.93
Retained Earnings	-388.42	-222.81	-116	-79.11	-54.39	-36.56
Comprehensive Income & Other	0	0.02	-	-	-	-
Total Common Equity	253.84	119.88	16.65	48.19	41.35	-35.63
Shareholders' Equity	253.84	119.88	16.65	48.19	41.35	3.26
Total Liabilities & Equity	296.22	148.54	24.05	57.93	44.53	5.06
Total Debt	2.77	1.65	0.29	-	0.61	0.56
Net Cash (Debt)	275.58	140.5	20.03	49.23	39.15	1.98
Net Cash Growth	620.74%	601.38%	-59.31%	25.73%	1878.42%	364.55%
Net Cash Per Share	6.62	7.08	1.65	4.27	11.55	1.81
Filing Date Shares Outstanding	60.05	59.69	12.22	12.13	10.66	1.1
Total Common Shares Outstanding	60.01	43.25	12.13	12.11	10.63	1.1
Working Capital	244.38	122.87	15.32	46.91	39.86	1.46
Book Value Per Share	4.23	2.77	1.37	3.98	3.89	-32.41
Tangible Book Value	253.84	119.88	16.65	48.19	41.35	-35.63
Tangible Book Value Per Share	4.23	2.77	1.37	3.98	3.89	-32.41
Machinery	-	5.75	3.94	3.69	3.62	1.94
Leasehold Improvements	-	0.23	0.19	0.19	0.19	0.18

Source: S&P Capital IQ. Standard template. Financial Sources.